These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. A case of the toxicity of pilsicainide hydrochloride with comparison of the serial serum pilsicainide levels and electrocardiographic findings. Horita Y; Kanaya H; Uno Y; Yamazaki T; Kaku B; Funada A; Kitajima S; Matsumura M; Satoh T Jpn Heart J; 2004 Nov; 45(6):1049-56. PubMed ID: 15655281 [TBL] [Abstract][Full Text] [Related]
7. Pilsicainide-induced Brugada-type ECG and ventricular arrhythmias originating from the left posterior fascicle in a case with Brugada syndrome associated with idiopathic left ventricular tachycardia. Ueyama T; Shimizu A; Esato M; Yoshiga Y; Sawa A; Suzuki S; Sugi N; Matsuzaki M Europace; 2008 Jan; 10(1):86-90. PubMed ID: 18037690 [TBL] [Abstract][Full Text] [Related]
8. [Ventricular proarrhythmia in the rhythm-control therapy for atrial fibrillation]. Nishimura H Nihon Rinsho; 2007 Oct; 65 Suppl 8():430-5. PubMed ID: 18074576 [No Abstract] [Full Text] [Related]
12. Unusual Wide Complex Tachycardia During Rhythm Control for Atrial Fibrillation. Banavalikar B; Shenthar J; Padmanabhan D Circulation; 2018 Jul; 138(5):537-539. PubMed ID: 30571524 [No Abstract] [Full Text] [Related]
13. Incidence and initial characteristics of pilsicainide-induced ventricular arrhythmias in patients with Brugada syndrome. Chinushi M; Komura S; Izumi D; Furushima H; Tanabe Y; Washizuka T; Aizawa Y Pacing Clin Electrophysiol; 2007 May; 30(5):662-71. PubMed ID: 17461877 [TBL] [Abstract][Full Text] [Related]
14. Effect of pilsicainide on dominant frequency in the right and left atria and pulmonary veins during atrial fibrillation: association with its atrial fibrillation terminating effect. Horiuchi D; Iwasa A; Sasaki K; Owada S; Kimura M; Sasaki S; Okumura K Eur J Pharmacol; 2009 Apr; 608(1-3):54-61. PubMed ID: 19268659 [TBL] [Abstract][Full Text] [Related]
16. Ventricular pacing failure after a single oral dose of pilsicainide in a patient with a permanent pacemaker and paroxysmal atrial fibrillation. Numata T; Abe H; Nagatomo T; Kohshi K; Nakashima Y Pacing Clin Electrophysiol; 2000 Sep; 23(9):1436-8. PubMed ID: 11025904 [TBL] [Abstract][Full Text] [Related]
17. [Ventricular tachycardia originating at the right ventricular outflow tract--surgical treatment of extrasystole]. Hayashi K; Watanabe N; Uchida S; Yamanishi H; Minami K; Abe H; Kawai H; Aoki I; Kisumino K; Ota S Rinsho Kyobu Geka; 1994 Feb; 14(1):72-3. PubMed ID: 9454287 [No Abstract] [Full Text] [Related]
18. A case of sinus pause due to the proarrhythmia of pilsicainide. Toeda T; Susa R; Saigawa T; Abe T; Yamaguchi Y; Fuse K; Murooka H Jpn Heart J; 2000 May; 41(3):405-10. PubMed ID: 10987357 [TBL] [Abstract][Full Text] [Related]
19. Dual tachycardia in the setting of amiodarone-induced hyperthyroidism. Daccarett M; Segerson NM; Weiss JP; Day JD Europace; 2007 Dec; 9(12):1217. PubMed ID: 17932021 [No Abstract] [Full Text] [Related]
20. [Case in which magnesium sulfate effectively treated ventricular tachycardia due to overdose of pilsicainide hydrochloride]. Nakata K; Moriwaki R; Yamaguchi A; Takenouchi S; Mato T; Tsutsumi H Chudoku Kenkyu; 2006 Jan; 19(1):49-53. PubMed ID: 16491881 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]